Skip to Content

MYLAN 1261 MYLAN 1261 (Propafenone Hydrochloride Extended-Release 425 mg)

Pill with imprint MYLAN 1261 MYLAN 1261 is Red / Orange, Capsule-shape and has been identified as Propafenone Hydrochloride Extended-Release 425 mg. It is supplied by Mylan Pharmaceuticals Inc..

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; wolff-parkinson-white syndrome; atrial flutter and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 1261 MYLAN 1261

Propafenone hydrochloride extended-release 425 mg MYLAN 1261 MYLAN 1261

Propafenone Hydrochloride Extended-Release

MYLAN 1261 MYLAN 1261
425 mg
Red / Orange
23.00 mm
Prescription only
Drug Class
Group i antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
National Drug Code (NDC)
Inactive Ingredients
silicon dioxide, magnesium stearate, ferric oxide red, sodium lauryl sulfate, titanium dioxide, ammonia, ferrosoferric oxide, propylene glycol, shellac, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.